Cargando…

Latent autoimmune diabetes in adults in China

Latent autoimmune diabetes in adults (LADA) is a type of diabetes caused by slow progression of autoimmune damage to pancreatic beta cells. According to the etiological classification, LADA should belong to the autoimmune subtype of type 1 diabetes (T1D). Previous studies have found general immune g...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Junlin, Xiao, Zilin, Zhang, Ziwei, Luo, Shuoming, Zhou, Zhiguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454334/
https://www.ncbi.nlm.nih.gov/pubmed/36090989
http://dx.doi.org/10.3389/fimmu.2022.977413
_version_ 1784785326092320768
author Qiu, Junlin
Xiao, Zilin
Zhang, Ziwei
Luo, Shuoming
Zhou, Zhiguang
author_facet Qiu, Junlin
Xiao, Zilin
Zhang, Ziwei
Luo, Shuoming
Zhou, Zhiguang
author_sort Qiu, Junlin
collection PubMed
description Latent autoimmune diabetes in adults (LADA) is a type of diabetes caused by slow progression of autoimmune damage to pancreatic beta cells. According to the etiological classification, LADA should belong to the autoimmune subtype of type 1 diabetes (T1D). Previous studies have found general immune genetic effects associated with LADA, but there are also some racial differences. Multicenter studies have been conducted in different countries worldwide, but it is still unclear how the Chinese and Caucasian populations differ. The epidemiology and phenotypic characteristics of LADA may vary between Caucasian and Chinese diabetic patients as lifestyle, food habits, and body mass index differ between these two populations. The prevalence of LADA in China has reached a high level compared to other countries. The prevalence of LADA in China has reached a high level compared to other countries, and the number of patients with LADA ranks first in the world. Previous studies have found general immune genetic effects associated with LADA, but some racial differences also exist. The prevalence of LADA among newly diagnosed type 2 diabetes patients over the age of 30 years in China is 5.9%, and LADA patients account for 65% of the newly diagnosed T1D patients in the country. As a country with a large population, China has many people with LADA. A summary and analysis of these studies will enhance further understanding of LADA in China. In addition, comparing the similarities and differences between the Chinese and the Caucasian population from the perspectives of epidemiology, clinical, immunology and genetics will help to improve the understanding of LADA, and then promote LADA studies in individual populations.
format Online
Article
Text
id pubmed-9454334
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94543342022-09-09 Latent autoimmune diabetes in adults in China Qiu, Junlin Xiao, Zilin Zhang, Ziwei Luo, Shuoming Zhou, Zhiguang Front Immunol Immunology Latent autoimmune diabetes in adults (LADA) is a type of diabetes caused by slow progression of autoimmune damage to pancreatic beta cells. According to the etiological classification, LADA should belong to the autoimmune subtype of type 1 diabetes (T1D). Previous studies have found general immune genetic effects associated with LADA, but there are also some racial differences. Multicenter studies have been conducted in different countries worldwide, but it is still unclear how the Chinese and Caucasian populations differ. The epidemiology and phenotypic characteristics of LADA may vary between Caucasian and Chinese diabetic patients as lifestyle, food habits, and body mass index differ between these two populations. The prevalence of LADA in China has reached a high level compared to other countries. The prevalence of LADA in China has reached a high level compared to other countries, and the number of patients with LADA ranks first in the world. Previous studies have found general immune genetic effects associated with LADA, but some racial differences also exist. The prevalence of LADA among newly diagnosed type 2 diabetes patients over the age of 30 years in China is 5.9%, and LADA patients account for 65% of the newly diagnosed T1D patients in the country. As a country with a large population, China has many people with LADA. A summary and analysis of these studies will enhance further understanding of LADA in China. In addition, comparing the similarities and differences between the Chinese and the Caucasian population from the perspectives of epidemiology, clinical, immunology and genetics will help to improve the understanding of LADA, and then promote LADA studies in individual populations. Frontiers Media S.A. 2022-08-25 /pmc/articles/PMC9454334/ /pubmed/36090989 http://dx.doi.org/10.3389/fimmu.2022.977413 Text en Copyright © 2022 Qiu, Xiao, Zhang, Luo and Zhou https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Qiu, Junlin
Xiao, Zilin
Zhang, Ziwei
Luo, Shuoming
Zhou, Zhiguang
Latent autoimmune diabetes in adults in China
title Latent autoimmune diabetes in adults in China
title_full Latent autoimmune diabetes in adults in China
title_fullStr Latent autoimmune diabetes in adults in China
title_full_unstemmed Latent autoimmune diabetes in adults in China
title_short Latent autoimmune diabetes in adults in China
title_sort latent autoimmune diabetes in adults in china
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454334/
https://www.ncbi.nlm.nih.gov/pubmed/36090989
http://dx.doi.org/10.3389/fimmu.2022.977413
work_keys_str_mv AT qiujunlin latentautoimmunediabetesinadultsinchina
AT xiaozilin latentautoimmunediabetesinadultsinchina
AT zhangziwei latentautoimmunediabetesinadultsinchina
AT luoshuoming latentautoimmunediabetesinadultsinchina
AT zhouzhiguang latentautoimmunediabetesinadultsinchina